Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (790)	8/16/1998 11:12:00 PM
From: Doug Bean	Read Replies (1) \| Respond to of 1837

Vestor: Well it seems pretty good to me. At first blush i was somewhat disappointed because I thought that they might actually begin to make a few bucks .. But then I had to think that a couple of the new approvals won't kick in any cash yet. They have made a large move forward and they still have many new drugs in for approval. If ( as stated) these are bigger margin products and which are hard for others to make,,, the basis will be there for a profitable company . The big deal is still Cenestiin and thats where we will win big if/when it gets approval. Otherwise it still sit and wait for me.. If DRMD does drop into the 3s i will have to find a few more bucks and add to my position. You just know there is a POP waiting after the next approval. CRDoug